PT  - JOURNAL ARTICLE
AU  - José Lourenço
AU  - Sílvia C Barros
AU  - Líbia Zé-Zé
AU  - Daniel SC Damineli
AU  - Marta Giovanetti
AU  - Hugo C Osório
AU  - Fátima Amaro
AU  - Ana M Henriques
AU  - Fernanda Ramos
AU  - Tiago Luís
AU  - Margarida D Duarte
AU  - Teresa Fagulha
AU  - Maria J Alves
AU  - Uri Obolski
TI  - West Nile virus in Portugal
AID  - 10.1101/2021.02.02.21251021
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.02.21251021
4099  - http://medrxiv.org/content/early/2021/05/17/2021.02.02.21251021.short
4100  - http://medrxiv.org/content/early/2021/05/17/2021.02.02.21251021.full
AB  - West Nile virus (WNV) causes outbreaks with sustained spillover to humans in many European countries. Despite Portugal’s Mediterranean climate being adequate for WNV transmission, only four human infections have been detected there so far. Here, we offer an historical account of past WNV circulation and develop new, climate-driven insights on the geo-temporal suitability for WNV transmission in Portugal. WNV and vector related literature and database reviews were performed in the context of Portugal covering the time period 1966-2020, and local climate data were used to estimate WNV transmission suitability for the period 1981-2019. Reviewed data demonstrate that WNV-compatible vectors are abundant across the entire country, while molecular and serological evidence for WNV circulation has mostly been associated with the southern districts. Our estimated WNV transmission suitability was found to support geographical differences in transmission potential that favour the southern districts, with an increasing trend over the past forty years due to climate change. Empirical and theoretical evidence supports WNV circulation in Portugal, but it remains unclear whether the virus is endemic or sporadically transmitted. Given the recent public health emergencies related to WNV in other European countries and the findings herein described in relation to Portugal, our study supports a timely change towards a local WNV active surveillance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementRelevant funding is included in the Acknowledgements section of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethical issues with this manuscript.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is deposited in online repositories and links are included in this manuscript.